Adaptive platform trial hopes to bring new treatments to patients faster
Discovering a potential explanation for treatment resistance in skin cancer
28 February 2022Cholesterol-lowering drugs may slow down metastases
28 February 2022Adaptive platform trial hopes to bring new treatments to patients faster
A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial—the first platform trial for amyotrophic lateral sclerosis (ALS)—designed to accelerate the development of effective and breakthrough treatments for people with the illness.
